Vital Therapies Announces Upcoming Third Quarter Financial Results Conference Call With Webcast
October 18 2017 - 8:01AM
Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company
developing ELAD®, a cell-based therapy targeting the treatment of
acute forms of liver failure, will release its third quarter 2017
financial results after the market closes on Wednesday, October 25,
2017 followed by a conference call at 4:30 p.m. ET, which will be
open to the public via telephone and webcast. During the
conference call, the Company will review financial results and
discuss other business matters.
The conference call dial-in numbers are (855)
765-5682 for domestic callers and (919) 825-3204 for international
callers. The conference ID number for the call is 9042599.
Participants may access the live webcast via a link on the Vital
Therapies website in the Investors Relations section under Events
at: http://ir.vitaltherapies.com/. The webcast will be
archived on the Company's website shortly after completion of the
call.
For those unable to listen in at the designated
time, a conference call replay will be available for one week
following the conference call, from approximately 7:30 p.m. ET on
October 25, 2017 to 7:30 p.m. ET on November 1, 2017. The
conference call replay numbers for domestic and international
callers are (855) 859-2056 and (404) 537-3406, respectively. The
conference ID number for the replay is 9042599.
About Vital Therapies, Inc.
Vital Therapies, Inc. is a biotherapeutic
company developing a cell-based therapy targeting the treatment of
acute forms of liver failure. The Company's ELAD System is an
extracorporeal human allogeneic cellular liver therapy currently in
phase 3 clinical trials. Vital Therapies, Inc. is based in
San Diego, California. Vital Therapies® and ELAD® are
trademarks of Vital Therapies, Inc.
Contact:
Vital Therapies, Inc. Al Kildani Vice
President, Investor Relations and Business Development
858-673-6840akildani@vitaltherapies.com
VITAL THERAPIES INC (NASDAQ:VTL)
Historical Stock Chart
From Mar 2024 to Apr 2024
VITAL THERAPIES INC (NASDAQ:VTL)
Historical Stock Chart
From Apr 2023 to Apr 2024